OR10H3
gene geneOn this page
Summary
OR10H3 (olfactory receptor family 10 subfamily H member 3, HGNC:8174) is a protein-coding gene on chromosome 19p13.12, encoding Olfactory receptor 10H3 (O60404). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26532 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_013938
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8174 |
| Approved symbol | OR10H3 |
| Name | olfactory receptor family 10 subfamily H member 3 |
| Location | 19p13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000171936 |
| Ensembl biotype | protein_coding |
| Entrez | 26532 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641646
RefSeq mRNA: 1 — MANE Select: NM_013938
NM_013938
CCDS: CCDS12334
Canonical transcript exons
ENST00000641646 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811708 | 15741382 | 15742343 |
| ENSE00003812183 | 15737985 | 15738051 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 71.22.
Top tissues by expression
263 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 71.22 | silver quality |
| ileal mucosa | UBERON:0000331 | 69.35 | silver quality |
| tibialis anterior | UBERON:0001385 | 65.42 | silver quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| deltoid | UBERON:0001476 | 55.00 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 53.14 | silver quality |
| hair follicle | UBERON:0002073 | 52.43 | gold quality |
| cranial nerve II | UBERON:0000941 | 51.11 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.08 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.87 | gold quality |
| oocyte | CL:0000023 | 49.68 | gold quality |
| thymus | UBERON:0002370 | 49.54 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 49.07 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.00 | gold quality |
| skin of hip | UBERON:0001554 | 47.93 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| cardia of stomach | UBERON:0001162 | 47.88 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.32 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or10h28 | ENSMUSG00000054666 |
| rattus_norvegicus | ENSRNOG00000077038 | |
| rattus_norvegicus | ENSRNOG00000089697 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761), OR8H2 (ENSG00000181767)
Protein
Protein identifiers
Olfactory receptor 10H3 — O60404 (reviewed: O60404)
Alternative names: Olfactory receptor OR19-24
All UniProt accessions (2): O60404, A0A126GW93
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_039226* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 5, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60404-F1 | 86.84 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 98–190
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 55 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, MORF_RAD51L3, MODULE_289, MORF_IL4, MORF_PRKCA, KEGG_OLFACTORY_TRANSDUCTION, MORF_THPO, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, MORF_ATF2, chr19p13, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, MORF_MAP2K7, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR10H3 | ADGRF3 | Q8IZF5 | 446 |
| OR10H3 | MINDY4 | Q4G0A6 | 404 |
| OR10H3 | GJC3 | Q8NFK1 | 356 |
| OR10H3 | TAAR5 | O14804 | 348 |
| OR10H3 | GPR31 | O00270 | 330 |
| OR10H3 | GPRC5D | Q9NZD1 | 324 |
| OR10H3 | MINDY3 | Q9H8M7 | 323 |
| OR10H3 | GPR37L1 | O60883 | 323 |
| OR10H3 | SORCS2 | Q96PQ0 | 311 |
| OR10H3 | COL21A1 | Q96P44 | 305 |
| OR10H3 | GJA3 | Q9Y6H8 | 276 |
| OR10H3 | ADGRB3 | O60242 | 270 |
| OR10H3 | AQP12B | A6NM10 | 270 |
| OR10H3 | EXOC3 | O60645 | 258 |
| OR10H3 | GJA8 | P48165 | 256 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR10H3 | HMGCS1 | psi-mi:“MI:0914”(association) | 0.530 |
| OR10H3 | NME2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (17): CYB5A (Affinity Capture-MS), LASP1 (Affinity Capture-MS), PAK2 (Affinity Capture-MS), FAHD1 (Affinity Capture-MS), HMGCS1 (Affinity Capture-MS), FAHD1 (Affinity Capture-MS), PAK2 (Affinity Capture-MS), HMGCS1 (Affinity Capture-MS), IRGQ (Affinity Capture-MS), LASP1 (Affinity Capture-MS), PLS1 (Affinity Capture-MS), LASP1 (Affinity Capture-MS), IRGQ (Affinity Capture-MS), PLS1 (Affinity Capture-MS), PAK2 (Affinity Capture-MS)
ESM2 similar proteins: A4D2G3, O60403, O60404, O76001, O76002, O95371, P23266, P23267, P30953, P34984, P58173, Q13607, Q5JQS5, Q60885, Q7Z3T1, Q8N148, Q8N628, Q8NG76, Q8NG77, Q8NG97, Q8NGA6, Q8NGF6, Q8NGN1, Q8NGQ2, Q8NGQ4, Q8NGT2, Q8NGT7, Q8NGT9, Q8NGX0, Q8NGY1, Q8NGY5, Q8NGZ5, Q8NGZ6, Q8NHB1, Q8VGD6, Q96KK4, Q96R30, Q96R45, Q96R47, Q96R48
Diamond homologs: A4D2G3, O43749, O60403, O60404, O76099, P0C629, P0DN81, P23270, P30953, P30954, P34984, P34986, P58173, P58181, P70526, Q13606, Q5JRS4, Q60880, Q60890, Q62007, Q6IF99, Q6IFH4, Q6UXT6, Q7TR96, Q8N127, Q8NG75, Q8NGA5, Q8NGA6, Q8NGC0, Q8NGC3, Q8NGC5, Q8NGE3, Q8NGE5, Q8NGF4, Q8NGG3, Q8NGI7, Q8NGI9, Q8NGJ0, Q8NGN3, Q8NGN4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
341 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:15741797:GCTAA:G | donor_gain | 0.7800 |
| 19:15741712:T:G | donor_gain | 0.7600 |
| 19:15741849:G:GA | donor_gain | 0.7600 |
| 19:15741798:C:G | donor_gain | 0.7500 |
| 19:15741801:A:AG | donor_gain | 0.7500 |
| 19:15741695:G:GT | donor_gain | 0.7400 |
| 19:15741848:T:TA | donor_gain | 0.7400 |
| 19:15742063:T:TA | acceptor_gain | 0.7000 |
| 19:15741935:T:G | acceptor_gain | 0.6900 |
| 19:15741761:C:CG | donor_gain | 0.6600 |
| 19:15741682:C:T | donor_gain | 0.6500 |
| 19:15741571:T:G | donor_gain | 0.6400 |
| 19:15741695:GAT:G | donor_gain | 0.6400 |
| 19:15741747:A:AG | donor_gain | 0.6400 |
| 19:15741745:TC:T | donor_gain | 0.6200 |
| 19:15741572:G:GG | donor_gain | 0.6100 |
| 19:15741746:C:A | donor_gain | 0.6100 |
| 19:15741801:A:G | donor_gain | 0.6100 |
| 19:15741953:GTT:G | acceptor_gain | 0.6000 |
| 19:15742059:ATTGT:A | acceptor_gain | 0.5900 |
| 19:15741539:A:AG | donor_gain | 0.5800 |
| 19:15741540:G:GG | donor_gain | 0.5800 |
| 19:15741750:GGC:G | donor_gain | 0.5800 |
| 19:15741751:GC:G | donor_gain | 0.5800 |
| 19:15741873:A:AG | donor_gain | 0.5800 |
| 19:15742064:G:A | acceptor_gain | 0.5800 |
| 19:15741752:C:G | donor_gain | 0.5600 |
| 19:15741952:AGTT:A | acceptor_gain | 0.5600 |
| 19:15741953:GTTG:G | acceptor_gain | 0.5600 |
| 19:15741742:T:TA | acceptor_gain | 0.5500 |
AlphaMissense
2110 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:15741426:T:C | F12L | 0.877 |
| 19:15741428:T:A | F12L | 0.877 |
| 19:15741428:T:G | F12L | 0.877 |
| 19:15741897:T:C | F169L | 0.867 |
| 19:15741899:C:A | F169L | 0.867 |
| 19:15741899:C:G | F169L | 0.867 |
| 19:15741441:T:C | F17L | 0.847 |
| 19:15741443:C:A | F17L | 0.847 |
| 19:15741443:C:G | F17L | 0.847 |
| 19:15741885:T:C | F165L | 0.839 |
| 19:15741887:T:A | F165L | 0.839 |
| 19:15741887:T:G | F165L | 0.839 |
| 19:15741924:T:C | F178L | 0.780 |
| 19:15741926:T:A | F178L | 0.780 |
| 19:15741926:T:G | F178L | 0.780 |
| 19:15742266:T:C | F292L | 0.776 |
| 19:15742268:C:A | F292L | 0.776 |
| 19:15742268:C:G | F292L | 0.776 |
| 19:15741477:T:C | F29L | 0.737 |
| 19:15741479:C:A | F29L | 0.737 |
| 19:15741479:C:G | F29L | 0.737 |
| 19:15741699:T:C | F103L | 0.724 |
| 19:15741701:C:A | F103L | 0.724 |
| 19:15741701:C:G | F103L | 0.724 |
| 19:15741498:T:C | F36L | 0.717 |
| 19:15741500:C:A | F36L | 0.717 |
| 19:15741500:C:G | F36L | 0.717 |
| 19:15741612:T:C | F74L | 0.715 |
| 19:15741614:C:A | F74L | 0.715 |
| 19:15741614:C:G | F74L | 0.715 |
dbSNP variants (sampled 300 via entrez): RS1000236121 (19:15741976 C>G), RS1000833902 (19:15738173 TTG>T), RS1001069507 (19:15737946 G>A,C), RS1001461725 (19:15737862 C>T), RS1001514495 (19:15742575 G>A), RS1001904422 (19:15738236 G>A,T), RS1002622740 (19:15739686 G>A), RS1002965783 (19:15740864 G>A,C), RS1003241877 (19:15736326 C>T), RS1004201002 (19:15736556 A>G), RS1004489279 (19:15741198 A>C,G), RS1005252318 (19:15738885 T>C), RS1005366312 (19:15737501 G>T), RS1005649224 (19:15738599 A>C,G), RS1006142866 (19:15740525 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium | increases abundance, decreases expression | 2 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.